Symbol="HILS"
AssetType="Common Stock"
Name="Hillstream Biopharma Inc"
Description="Hillstream BioPharma, Inc., a preclinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anticancer mechanism that causes iron-mediated cell death (IMCD) for refractory cancers. The company is headquartered in Bridgewater, New Jersey."
CIK="1861657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1200 ROUTE 22 EAST, BRIDGEWATER, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="6470100"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.278"
DividendPerShare="0"
DividendYield="0"
EPS="-0.71"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.641"
ReturnOnEquityTTM="-1.214"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.71"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.883"
EVToRevenue="-"
EVToEBITDA="-3.513"
Beta="None"
num_52WeekHigh="2.059"
num_52WeekLow="0.303"
num_50DayMovingAverage="0.378"
num_200DayMovingAverage="0.65"
SharesOutstanding="16814100"
DividendDate="None"
ExDividendDate="None"
symbol="HILS"
open="0.40"
high="0.41"
low="0.37"
price="0.38"
volume="476935.00"
latest_trading_day="2023-07-21"
previous_close="0.41"
change="-0.03"
change_percent="-7.1877%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="59"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="41"
Volume_recent_avg="525109"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.76"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="41"
Aroon_momentum_negative="59"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="595"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_positive_thumbnail_id_1="953"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_positive_thumbnail_id_2="620"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
